Peter J Wilkinson's Net Worth
$3.14 Million
Who is Peter J Wilkinson?
Peter J Wilkinson has an estimated net worth of $3.14 Million. This is based on reported shares across multiple companies, which include LABORATORY CORP OF AMERICA HOLDINGS, and PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
SEC CIK
Peter J Wilkinson's CIK is 0001398138
Past Insider Trading and Trends
2022 was Peter J Wilkinson's most active year for acquiring shares with 9 total transactions. Peter J Wilkinson's most active month to acquire stocks was the month of January. 2022 was Peter J Wilkinson's most active year for disposing of shares, totalling 15 transactions. Peter J Wilkinson's most active month to dispose stocks was the month of January. 2021 saw Peter J Wilkinson paying a total of $340,251.30 for 4,783 shares, this is the most they've acquired in one year. In 2021 Peter J Wilkinson cashed out on 5,881 shares for a total of $638,576.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91
SVP, Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -53.89% | -2.44K |
$204.33 | -$498,358.43 | 2.09K |
Apr 29
| |||
Form 4
| +93.33% | 2.19K |
$216.57 | -$193,613.58 | 4.53K |
Mar 27
| |||
Form 4
| +3.54% | 80 |
$227.45 | -$9,780.35 | 2.34K |
Feb 11 - Feb 12
| |||
Form 4
| +4.05% | 88 |
$223.71 | -$10,290.66 | 2.26K |
Feb 6 - Feb 7
| |||
Form 4
| +4.12% | 86 |
$221.54 | -$9,969.30 | 2.17K |
Feb 2
| |||
Form 4
| -39.87% | -1.38K |
$210.71 | -$291,626.79 | 2.09K |
Nov 16
| |||
Form 4
| +1.14% | 39 |
$213.61 | -$3,631.37 | 3.47K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +58.88% | 1.27K |
$224.70 | -$118,192.20 | 3.43K |
Mar 30
| |||
Form 4
| +3.45% | 72 |
$248.13 | -$9,428.94 | 2.16K |
Feb 11 - Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +4.92% | 98 |
$244.50 | -$12,714.00 | 2.09K |
Feb 4 - Feb 6
| |||
Form 4
| +3.97% | 76 |
$254.99 | -$10,454.59 | 1.99K |
Feb 2
| |||
Form 4
| -48.21% | -1.78K |
$202.49 | -$671,567.18 | 1.91K |
Aug 1
| |||
Form 4
| +106.58% | 1.91K |
$276.42 | -$252,924.30 | 3.7K |
Mar 27 - Mar 28
| |||
Form 4
| +51.22% | 606 |
$272.68 | -$71,169.48 | 1.79K |
Feb 11 - Feb 14
| |||
Form 4
| +8.93% | 97 |
$277.48 | -$14,706.44 | 1.18K |
Feb 4
| |||
Form 4
| +7.42% | 75 |
$273.18 | -$11,200.38 | 1.09K |
Feb 2
| |||
Form 4
| +3.59% | 35 |
$297.61 | -$4,464.15 | 1.01K |
Aug 1 - Aug 2
| |||
Form 4
| +86.58% | 453 |
$199.14 | -$622,251.71 | 976.22 |
Feb 12 - Feb 18
| |||
Form 4
| +22.76% | 97 |
$223.78 | -$11,860.34 | 523.22 |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| -50.00% | -297.00 |
$189.65 | -$56,325.72 | 297 |
Feb 21
| |||
Form 4
|
∞
| 594 |
$187.51 | -$51,002.72 | 594 |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMACEUTICAL PRODUCT DEVELOPMENT INC No price found
VP Fin./Chief Acctg. Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +74.68% | 354 |
$26.11 | $9,242.94 | 828 |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
| +103.43% | 241 |
$36.33 | $8,755.53 | 474 |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
∞
| 233 |
$34.44 | $8,024.52 | 233 |
Dec 31
| |||
Form 4
|
—
|
0
|
$27.52 | -$174,253.08 |
0
|
Nov 27
| |||
Form 4
| -100.00% | -1.29K |
$36.75 | -$47,294.54 |
0
|
Aug 17
| |||
Form 4
| +18.31% | 199 |
$29.00 | $5,771.00 | 1.29K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||